Phase 2 trial tests dostarlimab plus chemotherapy before surgery in stage III colon cancer

◆ TRIAL DATA

The AZUR-4 trial is comparing neoadjuvant dostarlimab plus CAPEOX versus CAPEOX alone in previously untreated T4N0 or stage III mismatch repair proficient/microsatellite stable resectable colon cancer. (Clinical Colorectal Cancer)